Callum Glennen

ADOA merger continues to progress

Recent changes to bylaws and constitutions are slowly bringing together Australia’s two dispensing organisations, following a 2019 commitment by the representative bodies to merge. Read more

Treatment for CSCR found to have “no benefit”

New research from the University of Bristol and University Hospital Southampton has concluded that eplerenone offers no benefit for patients suffering from central serous chorioretinopathy (CSCR), and subsequently should no longer be prescribed for the condition. Read more